HealthCare Global Enterprises Board Approves Rights Issue Worth ₹42,500 Lakhs

HealthCare Global Enterprises Limited announced that its board of directors has approved a significant rights issue during their meeting held on February 17, 2026. The healthcare company's board unanimously approved the issuance of fully paid-up equity shares worth up to ₹42,500 Lakhs, marking a major capital raising initiative for the organization. Rights Issue Details The board approved the issuance of fully paid-up equity shares with a face value of ₹10 each, targeting eligible equity shareholders as on the record date. The rights issue will be conducted in accordance with applicable laws, including the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended. Parameter: Details Issue Amount: Up to ₹42,500 Lakhs Share Face Value: ₹10 each Issue Type: Rights issue to eligible shareholders Target Recipients: Eligible equity shareholders as on record date Regulatory Framework: SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018 Board Meeting Proceedings The board meeting commenced at 5:00 PM and concluded at 7:25 PM on February 17, 2026. This decision follows the company's prior intimation dated February 8, 2026, indicating that the rights issue had been under consideration by the management. Terms and Implementation The board has delegated authority to the Rights Issue Committee of the Board of Directors to determine the specific and detailed terms of the rights issue. Key aspects that will be finalized by the committee include: Issue price determination Rights entitlement ratio Record date specification Timing of the rights issue Terms of payment These details will be disclosed to the stock exchanges in due course as they are finalized by the authorized committee. Regulatory Compliance The rights issue is subject to obtaining necessary regulatory and statutory approvals as required under applicable laws. The company has filed the required disclosure pursuant to Regulation 30 of SEBI Listing Regulations, along with the circular requirements specified in SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024. Compliance Aspect: Status SEBI Regulation 30: Disclosure filed Regulatory Approvals: Subject to obtaining required approvals SEBI Circular Compliance: SEBI/HO/CFD/PoD2/CIR/P/0155 requirements met The rights issue represents a significant capital raising exercise for HealthCare Global Enterprises Limited, providing eligible shareholders with the opportunity to participate in the company's growth plans through additional equity investment. Healthcare global enterprises has announced a crucial board meeting scheduled for February 17, 2026, to consider a significant fund raise proposal. The company has formally notified stock exchanges about the upcoming deliberations on equity fundraising through rights issue mechanism. Board Meeting Details The Board of Directors meeting has been scheduled in compliance with regulatory requirements under SEBI Listing Regulations. The company issued the intimation on February 08, 2026, to both major stock exchanges where its shares are listed. Parameter: Details Meeting Date: Tuesday, February 17, 2026 Purpose: Fund raise through rights issue Regulatory Framework: Regulation 29 of SEBI Listing Regulations Approval Status: Subject to regulatory/statutory approvals Fund Raise Proposal The primary agenda involves considering and approving a proposal for fund raising through the issuance of equity shares via rights issue. This mechanism allows existing shareholders to purchase additional shares at a predetermined price, typically below market value. The proposal remains subject to applicable laws and requisite regulatory and statutory approvals. Trading Window Restrictions In adherence to insider trading prevention protocols, HealthCare Global Enterprises has implemented a trading window closure for all designated persons. This measure ensures compliance with SEBI's Prohibition of Insider Trading Regulations, 2015. Restriction Details: Timeline Closure Start: Monday, February 09, 2026 Closure End: Thursday, February 26, 2026 Applicable To: All Designated Persons Regulatory Basis: Company's Code of Conduct for Prevention of Insider Trading Regulatory Compliance The intimation has been issued pursuant to Regulation 29(1) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has formally communicated with both NSE and BSE compliance departments, ensuring transparent disclosure to market participants. The announcement reflects the company's commitment to maintaining regulatory compliance while exploring strategic funding options. Additional information regarding this development is available on the company's official website at hcgoncology.com. We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better. Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians. As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.